Loading clinical trials...
Loading clinical trials...
A Pilot Study of Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1
Conditions
Interventions
Ivosidenib
Locations
2
United States
Washington University School of Medicine
St Louis, Missouri, United States
Cleveland Clinic - Case Comprehensive Cancer Center
Cleveland, Ohio, United States
Start Date
April 1, 2022
Primary Completion Date
January 31, 2030
Completion Date
January 31, 2030
Last Updated
August 14, 2025
NCT06240754
NCT06063486
NCT06295965
NCT06788691
NCT06802146
NCT07435636
Lead Sponsor
Washington University School of Medicine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions